MB, Levis & Associates’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,500
| Closed | -$58K | – | 268 |
|
|
2025
Q1 | $58K | Sell |
1,500
-800
| -35% | -$30.9K | 0.03% | 112 |
|
|
2024
Q4 | $87.2K | Hold |
2,300
| – | – | 0.04% | 94 |
|
|
2024
Q3 | $96.4K | Sell |
2,300
-200
| -8% | -$8.39K | 0.05% | 85 |
|
|
2024
Q2 | $102K | Sell |
2,500
-177
| -7% | -$7.23K | 0.05% | 81 |
|
|
2024
Q1 | $111K | Buy |
2,677
+40
| +2% | +$1.66K | 0.06% | 79 |
|
|
2023
Q4 | $107K | Sell |
2,637
-4,894
| -65% | -$198K | 0.06% | 77 |
|
|
2023
Q3 | $295K | Buy |
7,531
+119
| +2% | +$4.66K | 0.19% | 51 |
|
|
2023
Q2 | $301K | Buy |
7,412
+112
| +2% | +$4.55K | 0.19% | 51 |
|
|
2023
Q1 | $306K | Hold |
7,300
| – | – | 0.21% | 49 |
|
|
2022
Q4 | $318K | Buy |
+7,300
| New | +$318K | 0.25% | 43 |
|